Taking Stock
Merrimack's Mulroy on Success of Pancreatic Drug Onivyde(Audio)
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:12:00
- Mais informações
Informações:
Sinopse
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Bob Mulroy, CEO of Merrimack Pharmaceuticals, on biotech earnings, consumer health and oncology, and its product pipeline. Broadcasting live from the Boston Convention and Exhibition Center.
